Biodesix Adds $6.1M to Series E Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Biodesix said today that it has expanded a series E offering that raised $8.3 million in December.

The company added $6.1 million in a follow-on sale, bringing total proceeds from the sale of series E preferred shares to $14.4 million.

Existing shareholders of the company provided all funds. The offering will remain open to current shareholders until September of 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.